Categories
Global Market Market Reports

Global Catheter Stabilization Device Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

In this report,Europe Catheter Stabilization Device Market will reach 411.53 Million USD by the end of 2025 with a CAGR of 2.05%

“The Europe Catheter Stabilization Device market is valued at 364.44 Million USD in 2019 and will reach 411.53 Million USD by the end of 2025, growing at a CAGR of 2.05% during 2019-2025.”

Catheter Stabilization Device is secured or stabilized to avoid accidental elimination, reduce trauma to the urethra and the bladder, and decrease inflammation of tissues. The main objective of catheter stabilization is to stop excessive pull or traction on the catheter.
Catheter Stabilization Devices are a more effective alternative to tape in helping to improve clinical outcomes, quality of care and economic efficiencies.

The sales market share of Europe Catheter Stabilization Device in hospitals, emergency clinics, home healthcare providers and diagnostic centers has been stable year by year, at 53.33%, 24.06%, 6.93% and 15.68% respectively in 2019, and for several consecutive years, the amplitude was within 0.5 percent. This indicates that the segment of the Catheter Stabilization Device in the European market tends to be fixed without great changes.

XYZ research center data shows that in the European market, peripheral catheter stabilization device accounts for 34.71% of the sales market share, which is the highest, followed by epidural, abdominal drainage tubes, central venous catheter, chest drainage tube, arterial devices, the sales market share accounts for 24.31%, 18.17%, 12.76%, 10.05% and 7.55%, respectively.

XYZ research center data shows that Germany is the biggest contributor to the catheter stabilization device revenue market, accounting for 25.98% of the total European market with a revenue of 94.67 million USD in 2019, followed by UK, 15.61% with a revenue of 56.89 million USD.

B. Braun is the largest company in the European catheter stabilization device market, accounting for 16.15% of the revenue market share in 2019. with a much larger market share of 9.25% – nearly seven percentage points higher than C.R.Bard.

Geographically, global Catheter Stabilization Device market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
B. Braun
C. R. Bard
3M
ConvaTec
Baxter
Smiths Medical
Djo Global
Merit Medical Systems
Halyard Health
Dale Medical
Centurion Medical Products
Derma Sciences
TIDI Products
Medline
Deroyal
CRYO-PUSH
Marpac Inc
Hebei Kanghui
Hunan Jinpeng
Interrad Medical
M. C. Johnson
BioDerm
Europe Other
Total

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Arterial Devices Securement Devices
Central Venous Catheter Securement Devices
Peripheral Securement Devices
Abdominal Drainage Tubes Securement Device
Epidural Securement Devices
Chest Drainage Tube Securement Device
Other
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Catheter Stabilization Device for each application, including
Hospitals
Emergency Clinics
Home Healthcare Providers
Diagnostic Centers
Production, consumption, revenue, market share and growth rate are the key targets for Catheter Stabilization Device from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2422-global-catheter-stabilization-device-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

USA Healthcare RCM Outsourcing Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“In this report, our team research the USA Healthcare RCM Outsourcing market by type, application, region and manufacturer 2013-2018 and forecast 2019-2024.”

For the region, type and application, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers’ sales, price, revenue, cost and gross profit and their changes. What’s more, we will display the main consumers, raw material manufacturers, distributors, etc.

Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Healthcare RCM Outsourcing for these regions, from 2012 to 2023 (forecast), including
Northeast
Midwest
South
West

USA Healthcare RCM Outsourcing market competition by top manufacturers/players, with Healthcare RCM Outsourcing sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Conifer Health Solutions
nthrive (Medassets + Precyse)
optum360
Change Healthcare (Emdeon)
McKesson RelayHealth
Parallon (HCA)
MedData (Cardon Outreach)
MedAssist (Firstsource)
The SSI Group
Availity
Accretive Health (R1 RCM Inc)
GeBBS Healthcare
Cerner

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Pre-intervention
Intervention
Post-intervention

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Healthcare RCM Outsourcing for each application, including
Small/Rural Hospitals
Community Hospitals
Large Hospitals & Academic Medical Centers

If you have any special requirements, please let us know and we will offer you the report as you want.

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1624-usa-healthcare-rcm-outsourcing-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Global Endoscope Reprocessing Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

In this report, the past four years, Endoscope reprocessing equipment market size to maintain the average annual growth rate of 5.81% from 1091 million $ in 2014 to 1447 million $ in 2019, our analysts believe that in the next few years, Endoscope reprocessing equipment market size will be further expanded, we expect that by 2025, The market size of the Endoscope reprocessing equipment will reach 1651 million $.

Endoscope reprocessing equipment here includes those called as (automated or manual) endoscope reprocessor, endoscope reprocessing system, endoscope washer-disinfector, sterilization machine/system, endoscope transport system, endoscope drying and storage cabinet.

On the basis of type, the market is classified into endoscope reprocessor, endoscope drying & storage cabinets, endoscope transport systems, and other auxiliary equipment. Hospitals segmented accounted for the largest market share in 2018

The report includes detailed company profiling of leading players of the global Endoscope Reprocessing Sales market such as Johnson & Johnson, Cantel Medical, Ecolab Inc, Olympus, Wassenburg Medical, Custom Ultrasonics, Steris, Steelco, Getinge, Endo-Technik W. Griesat, BES Rehab, ARC Healthcare Solutions, Belimed. Steris was the largest Endoscope Reprocessing Sales supplier in the world, accounting about 8.8% of global Endoscope Reprocessing Sales in 2018.

USA is the largest seller countries of Endoscope Reprocessing in the world in the past few years and it will keep increasing in the next few years.

This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
Johnson & Johnson
Cantel Medical
Ecolab Inc
Olympus
Wassenburg Medical
Custom Ultrasonics
Steris
Steelco
Getinge
Endo-Technik W. Griesat
BES Rehab
ARC Healthcare Solutions
Belimed

On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Endoscope Reprocessor
Endoscope Drying & Storage Cabinets
Endoscope Transport Systems
Other Auxiliary Equipment

By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
Hospitals
Independent Endoscope Reprocessing Stations

By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2428-global-endoscope-reprocessing-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Lab Automation Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

Automation is one of the best weapon in the life science laboratory due to the growing demands for productivity in speed, accuracy, throughput and efficiency. Helped by advance technology, contemporary automated systems are already adept of a wide range of functions that were previously performed by slow, tedious and manual labor. Instrumentation continues to evolve, and is poised to tackle tasks that were not even conceivable just a few years ago. Originally used mostly by the big pharmaceutical and biotechnology companies, laboratory automation technology has quickly developed to satisfy a larger pool of clinical experts in the life science industry. Automation companies not only produce automation for specific customer needs but also smaller, easy-to-use systems that are much more accessible to clinical experts to satisfy their general needs. It is likely that Lab Automation market will reach more than US$ 16 Billion by the year 2022.

Clinical Automation Laboratory Market Analysis: In the clinical automation laboratory market, United States is seen as the dominant player followed by Europe and Japan will likely become second and third largest market. In terms of application, Work Station and LIMS are the leading market share taker in clinical laboratory automation market. It is anticipated that work station will lead the clinical lab automation market by the year 2022 followed by LIMS in 2nd position. Other applications of clinical lab automation such as sample transport system and specimen handling system will spot in 3rd and 4th position in clinical laboratory automation market.

Drug Discovery Automation Market Analysis:In the drug discovery automation market, United States is the hub for drug discovery. In 2015, United States hold XX% share of drug discovery automation market, which is expected to increase XX% by the year 2022. In terms of application, Plate readers has emerged as the largest market share taker in the drug discovery automation market followed by automated liquid system.

DPI Research report titled “Lab Automation Market – Global Industry Analysis and Opportunities Assessment 2012 – 2022” presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically-supported and industry-validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as market segments, regions, product types and major deals in the Lab Automation Industry.

Lab Automation Market has been analysed from 3 viewpoints:

1) Market and Forecast (2012 – 2022)
2) Segment wise Market & Forecast (2012 – 2022)
4) Region wise Lab Automation Market & Forecast (2012 – 2022)

Lab Automation Market – Application Segments Covered in the Report are:

1. Clinical Automation Laboratory
2. Drug Discovery Automation

The following segments of the Clinical Automation Laboratory market are detailed with size and six year forecast.

• Work Station
• Sample Transport System
• Storage Retrieval System
• Specimen Handling System
• Laboratory Information Management System (LIMS)

Furthermore, the following segments of the Drug Discovery Automation market are detailed with size and six year forecast.

• Automated Liquid Handling System
• Robotics
• Plate Readers
• Dissolution Testing
• Storage Retrieval System
• Laboratory Information Management System (LIMS)

The report analyses the market based on regions and presents the forecast in terms of value for the next six years. Regions covered in the report include:

• United States
• Europe
• Japan
• Brazil, Russia, India, China(BRIC)
• Rest of the world

Data Sources

The information contained in this report is based on both primary and secondary sources.

Primary Sources: Questionnaires, Surveys, telephonic interviews with industry experts and Observations

Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. DPI Research seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, Newspapers, Books, Government official websites and other paid database sources.

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1971-lab-automation-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

High Intensity Focused Ultrasound Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

High–Intensity Focused Ultrasound (HIFU) is a highly precise medical procedure that applies high–intensity focused ultrasound energy to locally heat and destroy diseased or damaged tissue through ablation. HIFU is one modality of therapeutic ultrasound, involving minimally invasive or non–invasive methods to direct acoustic energy into the body. In HIFU therapy, ultrasound beams are focused on diseased tissue, and due to the significant energy deposition at the focus, temperature within the tissue can rise to levels from 65° to 85°C, destroying the diseased tissue by coagulation necrosis.

Recent advances in HIFU, which was developed in the 1940s as a viable thermal tissue ablation approach, have increased its popularity. In clinics, HIFU has been applied to treat a variety of solid malignant tumors in a well–defined volume, including the pancreas, liver, prostate, breast, uterine fibroids, and soft–tissue sarcomas. In comparison to conventional tumor/cancer treatment modalities, such as open surgery, radio– and chemo–therapy, HIFU has the advantages of non–invasion, non–ionization, and fewer complications after treatment. More than 115, 000 cases have been treated throughout the world with great success till 2015.

High prevalence of cardiovascular diseases and cancer cases, rapidly growing aging population, rising number of new product launches, growing number of clinical studies regarding the applications of HIFU, and increasing focus of key players on the development of technologically advanced systems are the key factors driving the market growth.

Moreover, emerging applications such as gynecology & obstetrics, neurosurgery, urinary disorders imaging, and removal of excess subcutaneous fatty tissue using high–energy sound waves would further propel the growth of the high–intensity focused ultrasound market in the coming six years. However, the stringent government regulations for the approval of HIFU system, rising price pressure faced by market players and unfavorable of reimbursement scenario are the key factors restraining the growth of this market.

The Research report presents a comprehensive assessment of the HIFU manufacturers, research sites, pre–clinical research sites, clinical research sites, commercial treatment sites, treatment by indication. The report also brings together major distribution agreement, collaboration deals and partnership deals information in the HIFU market. Furthermore, each company have been profiled on the basis of various attributes such as company overview, HIFU products, latest developments, growth strategies and financial revenue.

The following 10 companies of the High Intensity Focused Ultrasound market are detailed with:

• Company Overview
• HIFU Products
• Companies HIFU Revenue
• Latest Development in High Intensity Focus Ultrasound (HIFU) Market

High Intensity Focused Ultrasound(HIFU) – 10 Companies covered

1) EDAP TMS
2) Sonacare Medical
3) Haifu Medical
4) Shanghai A&S Co., LTD
5) Mianyang Sonic Electronic Ltd.
6) Insightec
7) Theraclion
8) Alpinion Medical Systems
9) FUS Instruments
10) Image Guided Therapy

Research You Can Trust:

This reports are written by our research team, a dedicated group of analysts that knows the industry inside and out.

Data Sources

The information contained in this report is based on secondary sources.

Secondary Sources: Secondary data analysis and review involves collecting and analysing a vast array of information. Research team seeks information from different sources such as published articles, company websites, magazine articles, associations, trade journals, annual reports, newspapers, books, Government official websites and other paid database sources.

To request a sample copy or view summary of this report, click the link below:

https://bit.ly/2SFNpVl

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Medical Tourism Market, Trends, Analysis, Opportunities, Share and Forecast 2019-2025

Medical Tourism Market Overview:

The global medical tourism market was valued at $53,768 million in 2017 and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.

Organized travel across international borders to avail of medical treatment of some form, which may or may not be available in the travelers’ home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement, or restoration of their health through affordable healthcare facilities & treatments available in other countries, which are comparatively expensive in their own country. Medical tourists travel to receive medical treatments such as dental treatment, neurological treatment, cardiovascular treatment, and others.

The report segments the market into treatment type and region. Based on treatment type, the market is segmented into dental treatment, cosmetic treatment, cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and other treatments. Based on region, the medical tourism market is studied across North America (U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (India, China, Indonesia, Singapore, Malaysia, Thailand, South Korea, Taiwan, and, rest of Asia-Pacific), and LAMEA (Brazil, Venezuela, Costa Rica, UAE, South Africa, and rest of LAMEA).
Key Benefits for Medical Tourism Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets. It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Medical Tourism Key Market Segments:

By Treatment Type

Dental Treatment
Cosmetic Treatment
Cardiovascular Treatment
Orthopedic Treatment
Cardiovascular Treatment
Orthopedic Treatment
Neurological Treatment
Cancer Treatment
Fertility Treatment
Other Treatments

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
India
China
Indonesia
Singapore
Malaysia
Thailand
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Venezuela
Costa Rica
UAE
South Africa
Rest of LAMEA

List Of Key Players Profiled in the Report

Apollo Hospitals Enterprise Limited
Fortis Healthcare Limited
Asian Heart Institute
KPJ Healthcare Berhad
NTT Medical Center Tokyo
Seoul National University Hospital
UZ Leuven
Wooridul Spine Hospital
Aditya Birla Memorial Hospital
Barbados Fertility Center
Prince Court Medical Centre
Samitivej PCL.

List Of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request)

Bumrungrad International Hospital
Min-Sheng General Hospital
Raffles Medical Group
Bangkok Hospital Medical Center

To request a sample copy or view summary of this report, click the link below: http://digitsnmarkets.com/sample/2258-medical-tourism-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Global Hip Replacement Implants Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

Hip Replacement Implants Market: Overview

The global market overview for hip replacement implants looks promising considering advances in computer–assisted total hip replacement as well as the other technological platforms. The hip replacement implants market will continue to grow due to an aging population in much of the world.Increasing life spans and lifestyles impact the number of individuals with joints subject to failure, thereby increasing demand for hip replacement procedures. Additionally, the growing health awareness among masses, along with increase in the spending capacity of the population are propelling the market growth.

“Global hip replacement implants market is projected to reach more than US$ 5 Billion by 2021, at a CAGR of XX% from 2016 to 2021.”

Hip Replacement Implants Market: Country–wise Outlook

United States holds the highest share with more than 50% in 2015, and is expected that United States will maintain its position in the forecasting period. Japan and China hold the 2nd, and 3rd position in the hip replacement implants market. However, some of the European countries hip replacement implants market dwindle due to the EU austerity measures and the cutbacks in reimbursement have led to a decline over the past few years, while procedure numbers have still continued to grow in a modest way.
Hip Replacement Implants Market: Key Players Outlook

The global hip replacement market is dominated by Zimmer Biomet, Stryker, DePuy Synthes and Smith & Nephew. The three large players in the hip replacement implants market are Zimmer Biomet, DePuy Synthes and Stryker combined, they comprise almost more than 80% of the market. Other nominal yet important players of this market include Wright Medical, Exactech, DJO Global and many more. It is expected that Zimmer Biomet will emerge as a leading company in the hip replacement implants market in the forecasting period. The opportunity is immense in the emerging markets, as there is a large untapped population with the surgical need of hip implants.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes. The report concludes with the profiles of major players in the global hip replacement implants market such as Zimmer Biomet, Stryker, Smith & Nephew, Exactech, DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and revenue of hip replacement implants from 2008 to 2021.

The report covers in–depth analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2008 – 2015
• Market Size & Forecast 2016 to 2021
• Competition & Companies involved
• Deals Landscapes
• Market Growth Drivers and Challenges

Global Hip Implants Market is segmented as follows:

• Global – Hip Replacement Implants Market & Forecast (2008 – 2021)

• Global – Hip Replacement Implants Market Share & Forecast (2008 – 2021)

o Top 5 Company Market Share Outlook
o Top 10 Country Market Share Outlook

• Global Replacement Hip Implants Market – Top 10 Country Outlook

o United States
o Germany
o Italy
o France
o Spain
o United Kingdom
o Japan
o Brazil
o China
o India

• Global – Hip Replacement Implants Market: Key Company Analysis

o Zimmer Biomet
o Stryker
o DePuy Synthes (Johnson & Johnson)
o Smith & Nephew
o Exactech
o Other Companies

• Global Hip Replacement Implants Market: Deals Landscape

o Merger & Acquisitions
o Partnerships
o Collaboration
o Distribution Agreement

• Global Hip Replacement Implants Market: Growth & Challenges

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1973-global-hip-replacement-implants-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

Knee Implants Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

The global market overview for knee implants looks promising considering advances in computer–assisted total knee implants as well as other technological platforms. The knee implants market will continue to grow due to an aging population in much of the world.Increasing life spans and lifestyles impact the number of individuals with knee subject to failure, thereby increasing demand for knee replacement procedures. Additionally, the growing health awareness among masses, along with increase in the spending capacity of the population are propelling the market growth.

“Long–term Outlook: Global knee implants market is projected to reach more than US$ 7 Billion by 2021, at a CAGR of XX% from 2016 to 2021.”

Knee Implants Market: Country–wise Outlook
United States hold the highest share with more than 60% in 2015, and is expected that United States will maintain its position in the forecasting period. International markets such as India, China and Japan will show positive growth in the future and market share will increase to XX% by the year 2021. The opportunity is immense in the emerging markets, as there is a large untapped population with the surgical need of knee implants.
Knee Implants Market: Key Players Outlook

The global knee implants market is dominated by Zimmer Biomet, Stryker, DePuy Synthes and Smith & Nephew. The three large players in the knee implants market are Zimmer Biomet, DePuy Synthes and Stryker combined, they comprise almost more than 80% of the market. Other nominal yet important players of this market include Smith & Nephew, Exactech, DJO Global and many more. It is expected that Zimmer Biomet will emerge as a leading company in the knee implants market in the forecasting period.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes. The report concludes with the profiles of major players in the global knee implants market such as Zimmer Biomet, Stryker, Smith & Nephew, Exactech, DePuy Synthes(JnJ). The major market players are evaluated on various parameters such as company overview, product portfolio, and revenue of knee implants from 2008 to 2021.

The report covers in–depth analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2008 – 2015
• Market Size & Forecast 2016 to 2021
• Competition & Companies Involved
• Deals Landscapes
• Market Growth Drivers and Challenges

Global Knee Implants Market is segmented as follows:

Global – Knee Implants Market & Forecast (2008 – 2021)

Global – Knee Implants Market Share & Forecast (2008 – 2021)

• Company Market Share Outlook
• Country Market Share Outlook

Global Replacement Knee Implants Market – Country Outlook

• United States
• International

Global – Knee Implants Market: Key Company Analysis

• Zimmer Biomet
• Stryker
• DePuy Synthes (Johnson & Johnson)
• Smith & Nephew
• Exactech
• Other Companies

Global Knee Implants Market: Deals Landscape

• Merger & Acquisitions
• Partnerships
• Collaboration
• Distribution Agreement

Global Knee Implants Market: Growth & Challenges

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1974-knee-implants-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Hospital and Pre-Hospital External Defibrillator Market, Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The hospital and pre-hospital external defibrillators market was valued at $2,260 million in 2017 and is projected to reach $3,737 million by 2025, growing at a CAGR of 6.4% during the forecast period.”

In terms of volume, the hospital and pre-hospital external defibrillators market accounted for 727 thousand units in 2017 and is projected to reach 1,364 thousand units by 2025, growing at a CAGR of 8.1% during the forecast period.

External defibrillators are light weight and portable devices used to deliver a therapeutic shock to a patient’s heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. These devices are important to deliver a rapid response to the victims of cardiac arrest.

The external defibrillators market for hospital and pre-hospital is expected to experience significant growth owing to rapid rise in geriatric population with elevated risk of cardiovascular diseases, increase in incidence of cardiovascular diseases, and high presence of unmet medical needs especially in untapped economies, during the forecast period. However, limited insurance coverage and high cost of defibrillators is projected to impede the market growth. However, lucrative opportunities in emerging economies and surge in adoption of external defibrillators in hospital & pre-hospital treatment provide growth opportunities during the forecast period.

The global hospital and pre-hospital external defibrillators market is segmented into type, end user, and region. According to type, the market is bifurcated into manual external defibrillator and automated external defibrillator. Based on end user, the market is categorized into hospital (general wards, ICU, emergency room, and others) and pre-hospital (EMS, fire department, police, private transport companies, and others). Based on region, the market is studied across North America (U.S., and Canada), Latin America (Brazil and Mexico), Europe (Germany, France, the UK, Italy, Spain, Poland, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and rest of Asia-Pacific), and the Middle East and Africa (Saudi Arabia, South Africa, and rest of Middle East and Africa).

Key Benefits for Hospital and Pre-Hospital External Defibrillator Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Hospital And Pre-hospital External Defibrillator Market Key Market Segments:

By Type

Manual Defibrillators
Automated Defibrillators

By End User

Hospitals
General Wards
ICU
Emergency Room (ER)
Others
Pre-Hospital
Emergency Medical Services (EMS)
Fire Departments
Police
Private Transport Companies
Others

By Region

North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Poland
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle-East and Africa
Saudi Arabia
South Africa
Rest of Middle East and Africa

List of Key Players Profiled in the Report

Asahi Kasei Corporation
Aurora Capital Group. (Cardiac Science Corporation)
General electric company
Koninklijke Philips N.V.
MEDIANA CORPORATION
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
NIHON KOHDEN CORPORATION.
Progetti srl
SCHILLER AG
STRYKER CORPORATION

List Of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request.)

Bexen Cardio
Dixion Vertrieb medizinischer Geräte GmbH
WEINMANN Emergency Medical Technology GmbH
Seeuco Electronics Technology

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2257-hospital-and-pre-hospital-external-defibrillator-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

South Asia Flexible Endoscope Market, Trends, Analysis, Opportunities, Share and Forecast 2019-2025

Endoscopy is a minimally invasive medical procedure used for diagnosis, prevention, and treatment of complications in visceral organs. The device is either placed in the body through natural openings or cavities (such as anus and mouth) or through incisions, especially in case of arthroscopy. The South Asia flexible endoscope market was valued at $284 million in 2017, and is anticipated to reach $510 million by 2025, registering a CAGR of 7.4%.

Flexible endoscopy devices are equipped with several other parts such as camera or light source at the tip of endoscopes that help physicians or medical professionals to analyze the internal organs of interest. Endoscopy is used to evaluate various conditions such as stomach pain, ulcers, gastritis, digestive tract bleeding, cancerous growth in colon, and changes in bowel habits. Moreover, it is categorized based on the area of the body that are investigated. This includes knee & joints (arthroscopy), lungs (bronchoscopy), colon (colonoscopy), abdominal & pelvic areas (laparoscopy), and others. Increase in the incident rate of targeted diseases such as colon cancer and gastrointestinal disorders propels the demand for endoscopic devices.

Surge in geriatric population, which is highly susceptible to pain and chronic disorders, is expected to have a positive impact on the market growth. In addition, rise in need for the development of advanced minimally invasive surgical techniques is expected to augment the demand for endoscopic devices across healthcare settings. This in turn fuels the market growth. However, dearth of trained professionals for handling of endoscopic devices impedes the growth of the market. Conversely, high untapped potential in emerging economies is anticipated to offer significant profitable opportunities for market expansion.

The South Asia flexible endoscope market is segmented based on application into bronchoscopy, laparoscopy, arthroscopy, gastrointestinal endoscopy, urology endoscopy, neuro endoscopy, obstetrics/gynecology endoscopy, ENT endoscopy, and others. Depending on end user, the market is fragmented into hospitals, clinics, and others. Country wise, the market is analyzed across India, Pakistan, Bangladesh, Nepal, Sri Lanka, and rest of Asia.

Key Benefits flexible endoscope market:

The study provides an in-depth analysis of the South Asia flexible endoscope market along with the current trends and future estimations to elucidate the imminent investment pockets.
The report presents a quantitative analysis of the market from 2017 to 2025 to enable stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the market based on application assists in understanding the trends in the industry.
The key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

flexible endoscope Key Market Segments:

Market by Application

Bronchoscopy
Arthroscopy
Laparoscopy
Urology Endoscopy
Neuro Endoscopy
Gastrointestinal Endoscopy
Obstetrics/Gynecology Endoscopy
ENT Endoscopy
Others

By End User

Hospitals
Clinics
Others

By Country

India
Pakistan
Bangladesh
Sri Lanka
Nepal
Rest of South Asia

The list of key players operating in this market includes:

Boston Scientific Corporation
Conmed Corporation Magnum
Fujifilm Holdings Corporation
Johnson & Johnson (Ethicon, Inc.)
Hoya Corporation
Karl Storz GmbH & Co Kg.
Medtronic Plc
Olympus Corporation
Stryker Corporation
Vimex sp. z.o.o. (Vimex Endoscopy)

The other players included in the value chain analysis (and not included in the report) include:

Richard Wolf GmbH
Xion GmbH
Smith & Nephew plc
Hill Rom Holding, Inc

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2256-south-asia-flexible-endoscope-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

Global Breast Implants Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

Breast augmentation is one of the most popular cosmetic surgical procedures worldwide. The breast implants market is expected to grow at a steady pace driven by the popularity of breast augmentation procedures, rise in the disposable income of women, increasing beauty consciousness among the people. Furthermore, rising consumer awareness, greater emphasis to look good or aesthetic appearance, technology advancement and innovation are some of the other key driving factors in breast implants market.

Long–term Outlook: The global breast implants market, has witnessed a steady growth and is anticipated to grow with a healthy CAGR during the forecast period.

Breast Implants Market: Segment wise Outlook

The silicone breast implants segment is expected to grow at fast pace because of the popularity of highly cohesive silicone implants made of high strength silicone gel and textured with silicone shell. Silicone is the most preferred breast implants worldwide. It accounted for more than 80% market share in 2015. It is projected that silicone breast implants will gain the highest market share in the forecast period.

Breast Implants Market: Region wise Outlook

The Americas dominated the market, followed by the EMEA and APAC. The breast implants market in APAC is expected to grow at a faster pace than the market in the Americas because of the high acceptance of the procedure in China and South Korea. In the EMEA, the breast implants market is expected to grow slowly because of the safety concerns and decrease in spending power. It is likely that the Americas will lead the breast implants market with more than 60% market share by the year 2022.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. This report provides detailed analysis of global markets for breast implants from 2014-2015, and provides extensive market forecasts (2016-2022) by region/country and subsectors. The report covers key technological developments in the recent times and profiles leading players in the market and analyses their recent key development. The major players in the global breast implants market are Allergan, Mentor Worldwide, GC Aesthetics, Establishment Labs, Groupe Sebbin, Laboratories Arion, Kangning, Guangzhou Wanhe Plastic Materials and Sientra. The report also entails major drivers and challenges of breast implants market.

The report covers in–depth analysis on:

• Breast Implants Market Segments
• Breast Implants Market Dynamics
• Historical Actual Market Size, 2014 – 2015
• Market Size & Forecast 2016 to 2022
• Competition & Companies involved
• Market Growth Drivers and Challenges

Global Breast Implants Market is segmented as follows:

Breast Implants Market & Forecast (2014 –2022)

Breast Implants Market Share & Forecast (2014 – 2022)

• Breast Implants Segment Wise Market Share
• Breast Implants Region Wise Market Share

Breast Implants Market – By Segment

• Silicone Breast Implants
• Saline Breast Implants

Breast Implants Market: By Geography

• The Americas
• United States
• Rest of the Americas
• Europe, Middle East, & Africa (EMEA)
• Asia Pacific(APAC)

Cost Analysis of Breast Implant Procedures

Market Segmentation by Surgical Procedures

• Breast Augmentation
• Breast Reconstruction

Key Companies Analysis

• Allergan
• GC Aesthetics
• Mentor Worldwide LLC
• Sientra
• Arion Laboratories
• Establishment Labs
• Groupe Sebbin
• Guangzhou Wanhe Plastic Materials
• Kangning

Global Breast Implants Market: Growth & Challenges

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1976-global-breast-implants-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Varicose Vein Treatment Market, Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The global varicose vein treatment market was valued at $376.64 million in 2017, and is expected to reach $589.06 million by 2025, registering a CAGR of 5.7% from 2018 to 2025.”

Varicose veins are abnormal, dilated blood vessels caused by weakening of the vessel’s walls. These veins appear to be swollen, twisted, cluster of blue or purple veins under the skin. Varicose vein disorder affects millions of people all around the world Symptoms usually appear at the age of 40 and generally appear in the legs. Varicose vein is harmful to health if they lead to venous stasis ulcers, phlebitis, thrombosis, venous hemorrhage, or fungal and bacterial infections. According to the American Society of Vascular surgery, at least 20 to 25 million Americans are suffering from varicose vein, among them 17% are men and 33% are women.

Considerable rise in prevalence of varicose vein problem, surge in geriatric population, advanced varicose vein treatment devices, engagement in occupation that increases the prevalence of varicose vein treatment and technological advancements globally, boost the growth of the market. Whereas, increase in level of awareness as well as development in the emerging markets create numerous opportunities in the varicose vein treatment market.

The global varicose vein treatment market is segmented based on procedure, product, end user, and region. Based on procedure, the market is endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Based on product the market is segmented into ablation devices, sclerotherapy injection and others. Ablation devices is further divided into radiofrequency ablation devices, laser ablation devices and others. Based on end user, the market is divided into hospital, clinics, and ambulatory centers. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea and rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Key Benefits for varicose vein treatment market:

The study presents an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
varicose vein treatment Key Market Segments:

By Procedure

Injection Sclerotherapy
Endovenous Ablation
Surgical Ligation/Stripping
By Product

Sclerotherapy injection
Ablation Devices
Radiofrequency Ablation Devices
Laser Ablation Devices
Others
Others
By End User

Hospitals
Clinics
Ambulatory centers
By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT

Alma Lasers Ltd
Angiodynamics, Inc
Biolitec AG
BTG PLC
Energist Ltd
Medtronic
Lumenis
Sciton Inc
Syneron
WONTECH Co., Ltd.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

Teleflex
The Vein Company
F care Systems
Miravas
SharpLight Technologies

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2232-varicose-vein-treatment-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

Neurovascular Intervention Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The Global market for Neurovascular Intervention is projected to reach nearly US$4 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.”

Market growth can be attributed to factors such as rising prevalence of cerebrovascular disease and its associated risk factors, rise in the number of aging population, increasing knowledge of the symptoms of aneurysms and related diseases among patients, next generation of device platforms enters the market, long-term clinical data become available, appropriate treatment guidelines and reimbursement rates are established. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the market. High cost of treatment, unmet needs, scarcity of skilled neurosurgeons is restraining the growth of neurovascular interventional market.

United States is seen as the dominant player in the neurovascular intervention market. Emerging economies of India, China and Japan in the Asia-Pacific region and Latin American countries such as Brazil is slated to witness the highest growth in the forecasted period. The growth of the Asia-Pacific market is driven by improving healthcare facilities, gross domestic product (GDP) and increasing government investment.

On the basis of device, Coil represented the largest single category of products and accounted for XX% share in 2015. However, growth rate has slowed down in the segment which is being challenged by the emerging Carotid Stent, Microwire/Catheter and Clot Removal device. These three major devices grabbed the market share of XX% in 2015. It is expected that Coil will lead the neurovascular intervention market with XX% market share by the end of 2021.
Further, prudent analysis has been done on the competitor’s part, where four major players grab XX% of the global market by revenue. Stryker, Medtronic, Terumo, and DePuy Synthes are the key influencers with their products in the Neurovascular Intervention market. New releases, merger & acquisitions, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, diseases, geographies, companies, price trend, pipeline products, type of devices and competitive landscape. The report concludes with the profiles of major players in the global neurovascular intervention market such as Stryker, Medtronic, Terumo, and DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and revenue of neurovascular intervention segment from 2012 to 2021. The report also entails major drivers and challenges of neurovascular intervention market.

The report covers in–depth analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2009 – 2015
• Market Size & Forecast 2016 to 2021
• Competition & Companies involved
• Merger & Acquisitions
• Price Trend
• Pipeline Products Analysis
• Market Growth Drivers and Challenges

Neurovascular Intervention Market: Segmentation

Neurovascular Interventional market is classified on the basis of device type, disease type, company and geography.

Based on Device, the global neurovascular intervention market can be segmented as follows:

• Coil
• Carotid Stent
• Clot Removal
• Liquid Embolic
• Coil Assist Balloon
• Coil Assist Stent
• Flow Diverter Stent
• Micro wire/Catheter

Based on Disease, the global neurovascular intervention market can be segmented as follows:

• Aneurysm
• Intracranial Atherosclerotic Disease (ICAD)
• Ischemic Stroke
• Arteriovenous Malformation(AVM)

Based on Geography, the global neurovascular intervention market can be segmented as follows:

• United States
• France
• Germany
• Italy
• Spain
• United Kingdom
• Japan
• China
• India
• Brazil

Based on Company, the global neurovascular intervention market can be segmented as follows:

• Stryker
• Medtronic
• MicroVention (Terumo Corporation)
• De Puy Synthes

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1977-neurovascular-intervention-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Osseointegration Implants Market, Trends, Analysis, Opportunities, Share and Forecast 2019-2025

Osseointegration Implants Market By Product (Dental Implants And Bone-Anchored Prostheses), Material (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials, And Others), And End User (Hospital, Ambulatory Surgical Centers, And Dental Clinics): Global Opportunity Analysis And Industry Forecast, 2018 – 2025

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2231-osseointegration-implants-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

Global Neuroendovascular Coil and Non-Coil Devices Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The global neuroendovascular coil and non-coil devices market is estimated at US$ XX Billion in 2019 and projected to reach US$ XX Billion by 2025, growing at a CAGR of XX% during the forecast period.”

Cerebrovascular diseases include some of the most common and devastating disorders: ischemic stroke and hemorrhagic stroke. According to the World Health Organization, 15 Million people suffer stroke worldwide each year. Of these, 5 Million die and another 5 Million are permanently disabled. Stroke is the third leading cause of death in the United States. More than 140,000 people die each year from stroke in the United States. The incidence of cerebrovascular diseases increases with age, and the number of strokes is projected to increase as the elderly population grows, with a doubling in stroke deaths in the United States by 2030.

Drivers & Restraints

Market growth can be attributed to factors such as rising prevalence of cerebrovascular disease and its associated risk factors, rise in the number of aging population, increasing knowledge of the symptoms of aneurysms and related diseases among patients, next generation of device platforms enters the market, long-term clinical data become available, appropriate treatment guidelines and reimbursement rates are established. Rapid advances in the field of neuroendovascular devices and development of minimally invasive techniques have greatly expanded the market. High cost of treatment, unmet needs, scarcity of skilled neurosurgeons is restraining the growth of neuroendovascular coil & non-coil devices market.

Device Insights

Coil represented the largest single category of products and accounted for XX% share in 2015. However, growth rate has slowed down in the segment which is being challenged by the emerging Carotid Stent, Microwire/Catheter and Clot Removal device. These three major devices grabbed the market share of XX% in 2015. It is expected that Coil will lead the neuroendovascular coil & non-coil devices market with XX% market share by the end of 2021.

Country Insights

United States is seen as the dominant player in the neuroendovascular coil & non-coil devices market. Emerging economies of India, China and Japan in the Asia-Pacific region and Latin American countries such as Brazil is slated to witness the highest growth in the forecasted period. The growth of the Asia-Pacific market is driven by improving healthcare facilities, gross domestic product (GDP) and increasing government investment.

Company Insights

Prudent analysis has been done on the competitor’s part, where four major players grab XX% of the global market by revenue. Stryker, Medtronic, Terumo, and DePuy Synthes are the key influencers with their products in the neuroendovascular coil & non-coil devices market. New releases, merger & acquisitions, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projection using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, diseases, geographies, companies, price trend, pipeline products, type of coil & non-coil devices and competitive landscape.

The report concludes with the profiles of major players in the global neuroendovascular coil & non-coil devices market such as Stryker, Medtronic, Terumo, and DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales figures of neuroendovascular coil & non-coil devices segment from 2012 to 2021. The report also entails major drivers and challenges of neuroendovascular coil & non-coil devices market.

Market Segmentation

Neuroendovascular coil & non-coil devices market can be segmented based on

• Device Type
• Disease Type
• Company
• Geography

Based on Device, the global neuroendovascular coil & non-coil devices market can be segmented as follows:

• Coil
• Carotid Stent
• Clot Removal
• Liquid Embolic
• Coil Assist Balloon
• Coil Assist Stent
• Flow Diverter Stent
• Micro wire/Catheter

Based on Disease, the global neuroendovascular coil & non-coil devices market can be segmented as follows:

• Aneurysm
• Intracranial Atherosclerotic Disease (ICAD)
• Ischemic Stroke
• Arteriovenous Malformation(AVM)

Based on Geography, the global neuroendovascular coil & non-coil devices market can be segmented as follows:

• United States
• France
• Germany
• Italy
• Spain
• United Kingdom
• Japan
• China
• India
• Brazil

Based on Company, the global neuroendovascular coil & non-coil devices market can be segmented as follows:

• Stryker
• Medtronic
• MicroVention (Terumo Corporation)
• De Puy Synthes

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1978-global-neuroendovascular-coil-and-non-coil-devices-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Autoimmune Disease Therapeutics Market, Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is projected to reach $153,320 million by 2025, registering a CAGR of 4.2% from 2018 to 2025.”

Immune system disorders occur due to low activity or over activity of the immune system.
An autoimmune disease is a condition in which the immune system mistakenly attacks and damages its own tissues. There are more than 80 different autoimmune diseases exist. Some of the common types of autoimmune diseases are rheumatoid arthritis (RA), psoriasis/psoriatic arthritis, multiple sclerosis, systemic lupus erythematosus (lupus), inflammatory bowel disease, and others.

Autoimmune disease therapeutics are expected to experience significant market growth during the forecast period owing to early diagnosis of the disease, recent launch of advanced therapeutics, and rise in incidence of autoimmune disease. Furthermore, strong presence of late-stage pipeline drugs such as tocilizumab, baricitinib, certolizumab, secukinumab, etanercept, olokizumab, abatacept, apremilast, PF-06438179, golimumab, ustekinumab, etrolizumab, tofacitinib, and others. On the other side higher cost associated with the advanced therapeutics is expected to hamper the market growth.

The global autoimmune disease therapeutics market is segmented based on drug class, indication, sales channel, and region. Based on drug class, the market is classified as anti-inflammatory, antihyperglycemics, NSAIDs, interferons, and others. On the basis of indication, rheumatic disease, type 1 diabetes, multiple sclerosis, rare disease, inflammatory bowel disease, and other indications. According to the sales channel, the market is categorized as hospital pharmacy, drug stores & retail pharmacy, and online store. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, and rest of LAMEA).

Key Benefits for Autoimmune Disease Therapeutics Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
Autoimmune Disease Therapeutics Key Market Segments:

By Drug Class

Anti-inflammatory
Antihyperglycemics
NSAIDs
Interferons
Others
By Indication

Rheumatic Disease
Type 1 Diabetes
Multiple Sclerosis
Rare Disease
Inflammatory Bowel Disease
Other Indications
By Sales Channel

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Stores
By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT

Abbott Laboratories
AbbVie Inc.
Amgen Inc.
AstraZeneca plc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche AG
Johnson & Johnson
Novartis AG
Pfizer Inc.
UCB S.A.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)

Biogen Inc.
EMD Serono Inc.
GlaxoSmithKline plc
Shire Plc.
Teva Pharmaceutical Industries Ltd.

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2230-autoimmune-disease-therapeutics-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

Neuromodulation Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The Global market for Neuromodulation is projected to reach more than US$5 Billion by the end of 2021 growing at a CAGR of around XX% from 2019 to 2025.”

Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neuromodulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neuromodulation market.

North America is seen as the dominant player in the neuromodulation market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neuromodulation.

Spinal cord stimulation segment dominated the neuromodulation market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation. It is expected that deep brain stimulation will grasp nearly 20% market share by the year end of 2021.

Chronic Pain is identified as the largest application segment of the neuromodulation market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neuromodulation market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neuromodulation market.

Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the Neuromodulation market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape. The report concludes with the profiles of major players in the global neuromodulation such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neuromodulation segment from 2010 to 2021. The report also entails major drivers and challenges of neuromodulation market.

Neuromodulation Market: Segmentation

Neuromodulation market is classified on the basis of technology, application, company and geography.

Based on Technology, Neuromodulation market can be segmented as follows:

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation
• Vagus Nerve Stimulation
• Other Technologies

Based on Application, Neuromodulation market can be segmented as follows:

• Chronic Pain
• Parkinson’s Disease
• Urinary Fecal Incontinence
• Refractory Epilepsy
• Essential Tremor
• Dystonia
• Gastroparesis
• Treatment Resistant Depression(TRD)
• Obsessive Compulsive Disorder(OCD)
• Other Applications

Based on Geography, Neuromodulation market can be segmented as follows:

• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the World (ROW)

Based on Company, Neuromodulation market can be segmented as follows:

• Medtronic
• Boston Scientific
• St Jude Medical
• Liva Nova(Cyberonics)
• Nevro

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1979-neuromodulation-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

U.S. Thrombectomy Devices Market, Trends, Analysis, Opportunities, Share and Forecast 2019-2025

Thrombectomy is the surgical removal of blood clot from a blood vessel. Deep vein thrombosis is a life-threatening disease where blood clots within a vein. These clots can pass through to arteries or veins in different body parts—brain, heart, kidneys, lungs, and limbs. Similarly, venous thromboembolism (VTE) is considered as the cause of heart attack and stroke; however, it can damage body organs or may even lead to death. VTE results due to various factors such as combination of hereditary and acquired risk factors. It can be diagnosed in smoking population and people who consume estrogens or birth control pills. VTE is highly prevalent in adults (>60 years), however, can occur at any age.

“The U.S. thrombectomy devices market is was valued at $501.9 million in 2017, and is estimated to garner $750.4 million by 2025, registering a significant CAGR of 5.1% from 2018 to 2025. “

This is attributed to increase in incidence of acute myocardial infarction (AMI), peripheral artery disease (PAD), deep vein thrombosis (DVT), and pulmonary embolism (PE), due to sedentary lifestyle and unhealthy living conditions & habits along with rise in geriatric population in the U.S. Moreover, increase in incidence of cardiovascular diseases, surge in demand for minimally invasive procedures, rise in need for sophisticated healthcare infrastructure; and increase in market competition have led to technological advancements and innovations. However, lack of trained professionals & awareness and complicated use of these devices restrict the market growth. On the contrary, introduction of lasers & UV radiation and 3D imaging generation in thrombectomy devices is anticipated to provide lucrative growth opportunities to market players in the near future.

The U.S. thrombectomy devices market is segmented based on technology, type, utility, and disease. Depending on the type of technology, the market is categorized into mechanical, aspiration, and rheolytic thrombectomy devices. By type, it is bifurcated into automated and manual thrombectomy devices. As per utility, it is classified into reusable and disposable thrombectomy devices. On the basis of disease, it is divided into peripheral, neurovascular, and coronary thrombectomy devices.

Key Benefits for U.S. Thrombectomy Devices Market:

The U.S. thrombectomy report provides an extensive analysis of the current market trends and future estimations of the market.
The market scenario is comprehensively analyzed with respect to the technology, type, utility, and disease.
The U.S. thrombectomy devices market growth estimations in this report are based on high-end analysis of the key developments for 2018–2025.
Recent developments, key manufacturers, and market shares are listed in this report to analyze the competitive scenario of the market.
U.S. Thrombectomy Devices Key Market Segments:
By Technology

Mechanical Thrombectomy Devices
Aspiration Thrombectomy Devices
Rheolytic Thrombectomy Devices
By Type

Automated Thrombectomy Devices
Manual Thrombectomy Devices
By Disease

Peripheral Thrombectomy Devices
Coronary Thrombectomy Devices
Neural Thrombectomy Devices
By Utility

Reusable Thrombectomy Devices
Disposable Thrombectomy Devices
Key Market Players

Boston Scientific Corporation
Medtronic plc
Teleflex Incorporated
Penumbra, Inc.
Koninklijke Philips N.V.
AngioDynamics, Inc.
Terumo Corporation
Johnson and Johnson
Stryker Corporation
Capture Vascular, Inc.
The other players in the value chain include (profiles not included in the report)

Argon Medical Devices, Inc.
Inari Medical, Inc.

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2229-u.s.-thrombectomy-devices-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

Neurostimulation Devices Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The Global market for Neurostimulation Devices is expected to cross US$5 Billion by the year end of 2021.”

Drivers & Restraints

Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neurostimulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neurostimulation devices Market.

Segment Insights

Spinal cord stimulation segment dominated the neurostimulation devices market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation segment. It is expected that deep brain stimulation segment will grab nearly 20% market share by the year end of 2021.

Regional Insights

North America is seen as the dominant player in the neurostimulation devices market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neurostimulation devices market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neurostimulation.

Application Insights

Chronic Pain is identified as the largest application segment of the neurostimulation devices market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neurostimulation devices market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neurostimulation devices market.

Company Insights

Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the neurostimulation devices market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, geographies, companies and market dynamics. The report concludes with the profiles of major players in the global neurostimulation market such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neurostimulation devices segment from 2010 to 2021. The report also entails major drivers and barriers of neurostimulation devices market.

Neurostimulation Devices Market: Segmentation

Neurostimulation Devices Market is classified on the basis of device segment, application, company and geography.

Based on Segment, Neurostimulation Devices Market can be segmented as follows:

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation
• Vagus Nerve Stimulation
• Other Devices Segment

Based on Application, Neurostimulation Devices Market can be segmented as follows:

• Chronic Pain
• Parkinson’s Disease
• Urinary Fecal Incontinence
• Refractory Epilepsy
• Essential Tremor
• Dystonia
• Gastroparesis
• Treatment Resistant Depression(TRD)
• Obsessive Compulsive Disorder(OCD)
• Other Applications

Based on Geography, Neurostimulation Devices Market can be segmented as follows:

• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the World (ROW)

Based on Company, Neurostimulation Devices Market can be segmented as follows:

• Medtronic
• Boston Scientific
• St Jude Medical
• Liva Nova(Cyberonics)
• Nevro

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1980-neurostimulation-devices-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Cholera Vaccine Market, Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The global cholera vaccine market generated $65 million in 2017, and is projected to reach $207 million by 2025, growing at a CAGR of 15.6% from 2018 to 2025

Cholera is an acute intestinal infection that causes rapidly dehydrating diarrheal disease, which is caused by toxigenic serogroups of the bacterium Vibrio cholera. The disease is closely associated with poverty, poor sanitation, and lack of clean drinking water. Historically, devastating outbreaks of cholera resulted in millions of cases and hundreds of thousands of deaths. Currently, cholera remains an important public health problem in many countries, occurring as an endemic disease in some regions and causing major epidemics in some low- and middle-income countries (LMICs). The vaccine is used to control cholera and is mainly recommended for travelers and the people living in cholera-affected region.

There is an increase in the demand for cholera vaccine due to lack of proper sanitation & consumption of contaminated food and growth in the awareness about cholera preventive care. In addition, development of novel approaches for new cholera vaccine further drive the market growth. However, risk of adverse effects and the time taken for the regulatory approval is projected to impede the market growth. On the contrary, high growth opportunities in untapped markets are expected to offer significant profitable opportunities for the market players.

The global cholera vaccine market is segmented based on product, end user, and region. Based on product, the market is segmented into Dukoral, Shanchol, Vaxchora, Euvichol & Euvichol-Plus, and others. Depending on end user, the market is categorized into hospitals & clinics, research & academic laboratories, and others. Based on region, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits For Cholera Vaccine Market:

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global cholera vaccine market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
Cholera Vaccine Key Market Segments:
By Product

Dukoral
Shanchol
Vaxchora
Euvichol & Euvichol-Plus
Others
By End User

Hospitals & Clinics
Research & Academic Laboratories
Others
By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Sweden
Rest of Europe
Asia-Pacific
Australia
Japan
India
Vietnam
Rest of Asia-Pacific
LAMEA
Nigeria
Malawi
Zambia
Rest of LAMEA
Key Market Players

Valneva SE
Emergent BioSolutions, Inc. (PaxVax, Inc.)
Astellas Pharma, Inc.
Sanofi (Shantha Biotechnics Private Limited)
Eubiologics Co., Ltd.
Johnson & Johnson (Crucell)
Celldex Therapeutics, Inc.
The other players in the value chain include (profiles not included in the report):
Merck & Co., Inc.
GlaxoSmithKline plc.

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2228-cholera-vaccine-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

High Intensity Focused Ultrasound (HIFU) System Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

More than 570 commercial treatment sites treated over 115, 000 cases with HIFU system throughout the world with great success.

High Intensity Focused Ultrasound(HIFU) is a modality of therapeutic ultrasound and is a non–invasive method to deposit acoustic energy into tissue. In HIFU therapy, ultrasound beams are focused on diseased tissue, and due to the significant energy deposition at the focus, temperature within the tissue rises to 65° to 100°C, destroying the diseased tissue by coagulation necrosis. Each sonication of the beams treats a precisely defined portion of the targeted tissue.

Market growth can be attributed to factors such as increasing population base of cancer patients, technological advancements in HIFU devices, increasing number of commercial treatment centres, increasing demand for minimally invasive treatment procedures, and growing awareness regarding the benefits offered by HIFU procedures over those of conventional therapeutic.

The Research report presents a comprehensive assessment of the HIFU research sites, pre–clinical research sites, clinical research sites, technical research sites, commercial treatment sites and treatment by indication. Additionally, the report includes insight of clinical trials of the HIFU System. Key trends in terms of collaborations, distribution agreement and partnership deals are analyzed with details.

The report also includes comprehensive profiles of HIFU system manufacturers such Philips Healthcare, EDAP TMS, Sonacare Medical, Haifu Medical, Shanghai A&S Co., LTD, Mianyang Sonic Electronic Ltd., Insightec, Theraclion, Alpinion Medical Systems, FUS Instruments, Image Guided Therapy, Medsonic Ltd, Promedica Bioelectronics, Sumo Corporation Ltd and Mirabilis Medica. The thorough description of players includes parameters such as business overview, revenue, products analysis and recent development & trends of the manufacturers.

Global High Intensity Focused Ultrasound(HIFU) System Market – 15 Manufacturers covered

1) EDAP TMS
2) Philips Healthcare
3) Sonacare Medical
4) Haifu Medical
5) Shanghai A&S Co., LTD
6) Mianyang Sonic Electronic Ltd.
7) Insightec
8) Theraclion
9) Alpinion Medical Systems
10) FUS Instruments
11) Image Guided Therapy
12) Medsonic Ltd
13) Promedica Bioelectronics
14) Sumo Corporation Ltd
15) Mirabilis Medica

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1981-high-intensity-focused-ultrasound-(hifu)-system-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

United States Insulin Pump Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“United States Insulin Pump Market is likely to reach USD 4 Billion by the year-end of 2022.”

Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pumps is hampering the growth of this market.

The research report titled “United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users.

Market outlook in value terms for the forecasted period for Insulin Pump Market has been detailed in the report. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.

The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• United States Insulin Pump Users and Market Analysis (2011 – 2022)
• United States Insulin Pump Preferred Brand – By Product
• United States Insulin Pump Market: Reimbursement & Regulation System
• United States Insulin Pump Market – Major Deal Types
• Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States Insulin Pump Market

Key Companies Covered in the Report are as follows:

• Insulet Corporation
• Medtronic
• Roche
• Animas Corporation
• Tandem Diabetes Care

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1982-united-states-insulin-pump-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Industry Analysis Market Report Market Reports

Catheters Market, Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The global catheters market was valued at $10,703 million in 2017 and is estimated to reach $19,976 million by 2025, registering a CAGR of 8.0 % from 2018 to 2025.”

Catheters are the medical devices that are made up of medical grade material and are used for both diagnosis as well as treatment purposes. These are usually made of plastic, silicon rubber, polyvinyl chloride (PVC), and nylon, and can easily be inserted in the patient’s body. Catheters primarily allow drainage, administration of fluids in the patient’s body and are used to perform numerous other tasks depending on the type of catheter including cardiovascular, neurovascular, urological, and others.

High prevalence of cardiovascular diseases accompanied with the development of innovative cardiovascular catheters is the major factor that drives the market growth. Increase in prevalence of urological diseases such as urinary bladder cancer and kidney failure, has significantly fueled the demand for urological catheters. Also, novel products such as external male catheters, have proved to be a lucrative addition to the overall catheters and variants product lines for the catheters manufacturing companies. The increase in patient pool for ischemic and hemorrhagic stroke thereby increased the demand for minimally invasive neurovascular surgeries, thus making way for opportunities for the neurovascular catheters micro catheters and guiding catheters. Increase in cardiovascular diseases and growth in demand for minimal invasive surgeries drive the global catheters market. Rise in incidence of diabetes, cardiovascular diseases, urinary bladder, and kidney failures also fuel the market growth.

The catheters market is segmented based on product and region. Based on product, the market is divided into cardiovascular catheters, neurovascular catheters, urological catheters, intravenous catheters, specialty catheters. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits of Catheters Market:

The study provides an in-depth analysis of the global catheters market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the catheters market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Catheters Market Key Segments:

By Product

Cardiovascular Catheters
Electrophysiology Catheters
PTCA Balloons Catheters
IVUS Catheters
PTA Balloons Catheters
Others
Neurovascular Catheters
Urological Catheters
Dialysis Catheter
Hemodialysis Catheters
Peritoneal Catheters
Dialysis Catheter
Foley Catheters
Intermittent Catheters
External Catheters
Intravenous Catheters
Central Venous Catheters
Peripheral Venous Catheters
Integrated Catheters
Short Catheters
Specialty Catheters
Wound/Surgical Drain
Oximetry
Thermodilution
IUI Catheters
By Region

North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
France
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA
Key Market Players

Abbott Laboratories
Becton Dickinson And Company
Boston Scientific Corporation
Stryker Corporation
B. Braun Melsungen AG
Teleflex Incorporated
Johnson & Johnson
Medtronic, Inc
Edwards Lifesciences Corp
Cook Medical
The other players in the value chain include (profiles not included in the report)

Hollister Incorporated
Manfred Sauer
Smiths Medical
Wellspect Healthcare
Cure Medical
Convatech Inc

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2227-catheters-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

Insulin Pen Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year-end of 2022.”

Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices

Insulin Pen Users Insights

China is the leading consumers of insulin pen where XX% of the diabetic population prefer insulin pen. India and Germany have shown its potential to become 2nd and 3rd popular insulin pen users. United States is the fourth leading consumers of insulin pen. Japan and Brazil hold the fifth and sixth leading consumers of insulin pen.

In terms of reusable insulin pen users, China gained its top position as the biggest overall consumer of reusable insulin pen. India and Germany grabbed the #2 and #3 position with XX% and XX% share in 2016 and is likely to maintain its position till the forecast period.

In terms of prefilled insulin pen users, China is the top prefilled insulin pen consumer, followed by United States and Japan, a trio leading a prefilled insulin pen users share and is expected to witness the highest growth rate in the forecast period

Insulin Pen Market Insights

United States is expected to lead the insulin pen market with a total market share of over 20% by 2022. China and Japan held the #2 and #3 largest market share and is expected to maintain its dominant position during the forecast period.

In terms of Reusable Insulin Pen Market, China and Germany will lead the reusable insulin pen market with more than combined 75% market share by 2022.

In terms of Prefilled Insulin Pen Market, United States accounted for the largest share of the insulin pen market in 2016, followed by Japan and Germany. United States is expected to register the highest CAGR during the forecast period.

The research report titled “Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the Insulin Pen Market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into insulin pen users with more focused–on reusable and prefilled insulin pen users. Market outlook in value terms for the forecasted period for Insulin Pen Market has been detailed in the report. The insulin pen market is further segment into reusable and prefilled insulin pen market. The report also explores detailed description of growth drivers and inhibitors of the Insulin Pen Market.

The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market.

All the Ten Major Markets(10MM) Covered in the Report Have Studied from 8 Viewpoints

1. Overall Diabetes Population (2011 – 2022)
2. Insulin Users (2011 – 2022)
3. Insulin Pen Users (2011 – 2022)
4. Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
5. Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
6. Insulin Pen Market (2011 – 2022)
7. Reusable (Cartridge) Insulin Pen Market (2011 – 2022)
8. Prefilled (Disposable) Insulin Pen Market (2011 – 2022)

Ten Major Markets(10MM) Covered in the Report are as follows

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan
8. China
9. India
10. Brazil

Key Companies Covered in the Report are as follows

1. Novo Nordisk
2. Eli Lilly
3. Sanofi
4. Owen Mumford
5. Ypsomed
6. Biocon Ltd.

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1983-insulin-pen-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

United States Blood Glucose Meter Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“United States Blood Glucose Meter Market is likely to reach USD 650 Million by the year-end of 2022.”

Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes mellitus, improved glucose control and flexible, user–friendly design, government efforts for better management of diabetes mellitus and technological advancement in blood glucose meter devices.

The research report titled “United States Blood Glucose Meter Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Blood Glucose Meter Market. The study provides an in–depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. Moreover, it also provides an essential insight on insulin users.

The report provides a decisive view on the Blood Glucose Meter Users and Market. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States Blood Glucose Meter Market. Key trends in terms of collaboration, partnership, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Blood Glucose Meter Market. The report concludes with the profiles of major players in the United States Blood Glucose Meter Market. The key market players are evaluated on various parameters such as company overview, marketed products and latest development and trends of the Blood Glucose Meter Market.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• Insulin Users (2011 – 2022)
• United States Blood Glucose Meter Users and Market Analysis (2011 – 2022)
• United States Blood Glucose Meter Market: Reimbursement & Regulation System
• United States Blood Glucose Meter Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States Blood Glucose Meter Market

Key Companies Covered in the Report are as follows:

• Roche
• LifeScan Inc
• Abbott Diabetes Care
• Arkray
• Ascensia Diabetes Care
• Fora Care
• Entra Health
• Fifty50 Medical
• Infopia
• Genesis Health Technologies
• iHealth Labs
• Oak Tree Health
• Livongo Health
• Nova Diabetes Care
• Sanofi Diabetes
• Telcare
• Walgreens
• U.S. Diagnostics
• Prodigy Diabetes Care
• Omnis Health

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1984-united-states-blood-glucose-meter-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Biotechnology Media, Sera and Reagents Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The global biotechnology media, sera and reagents market was valued at $18,794 million in 2017 and is estimated to reach at $32,974 million by 2025, registering a CAGR of 7.3% from 2018 to 2025.”

Biotechnology is the branch of science that uses living organisms to make technological advancements and adapt those technologies to various different fields including agriculture, genetic engineering, novel drug developments, and several others. Media and sera find their application in animal tissue culture and plant tissue culture, while reagents are used in various biotechnology applications such as diagnosis, laboratory research, drug development, and others.

Considerable rise in the biotechnological R&D pertaining to the development of biopharmaceuticals has led to an increase in demand for culture media, sera, and reagents market. Moreover, increase in investments and funding for research interventions in both developed and developing countries further boost the market growth. However, ethical & scientific concerns associated with the potential of misuse of biotechnology research practices and dearth of skilled personnel restrict the market growth. On the contrary, untapped potential of the emerging economies is anticipated to provide lucrative opportunities to the key players involved in the biotechnology media, sera and reagents market in the near future.

The biotechnology media, sera and reagents media market is segmented based on type, application, end user, and region. Based on type, the market is divided into media, sera and reagents. The media segment is further bifurcated into lysogeny broth, classical media, serum free media, chemically defined media, specialty media, stem cell media and others. The sera segment is further classified into fetal bovine sera, new born calf sera, and others. Likewise, the reagents segment is further segmented into antibiotics, DNA/RNS isolation reagents, PCR reagents, buffers and others. Based on application, the market is categorized into cancer research, biopharmaceuticals, clinical diagnostics, regenerative medicine & tissue engineering, and others. Based on end user, it is classified into biotechnology & pharmaceutical industry, academic institute, research laboratory, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Biotechnology Media, Sera And Reagents Market:

The study provides an in-depth analysis of the global biotechnology media, sera and reagents market along with the current trends and future estimations to elucidate the imminent investment pockets.
A comprehensive analysis of the factors that drive and restrict the market growth is provided.
A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
An extensive analysis of the key segments of the industry helps understand the global trends in the biotechnology media, sera and reagents market.
Key players and their strategies are provided to understand the competitive outlook of the industry.
Biotechnology Media, Sera And Reagents Key Market Segments:
By Type

Media
Lysogeny Broth
Classical Media
Serum Free Media
Chemically Defined Media
Specialty Media
Stem Cell Media
Others
Sera
Fetal Bovine Sera
New Born Calf Sera
Others
Reagents
Antibiotics
DNA/RNS Isolation Reagents
PCR Reagents
Buffers
Others
By Application

Cancer Research
Biopharmaceuticals
Regenerative Medicine & Tissue Engineering
Others
By End User

Biotechnology & Pharmaceutical Companies
Academic Institute
Research Laboratory
Others
By Region

North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
France
Rest of Europe
Asia-Pacific
Japan
China
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Saudi Arabia
South Africa
Brazil
Rest of LAMEA
Key Market Players

GE Healthcare
Bio-Rad Laboratories Inc.
Merck KGaA (Sigma Aldrich)
Sartorius AG
HiMedia Laboratories Pvt., Ltd
Lonza Group Ltd
Merck & Co., Inc.
Thermofisher Scientific
Corning Incorporated
Becton, Dickinson and Company
The other players in the value chain include (profiles not included in the report)

Avantor Performance Materials, LLC
Caisson Laboratories, Inc
Cell Culture Technologies LLC
Fujifilm Holdings Corporation
Sera Scandia A/S (Biowest)
Vitro Diagnostics, Inc.
Cyagen Biosciences

To request a sample copy or view summary of this report, click the link below:

http://digitsnmarkets.com/sample/2226-biotechnology-media,-sera-and-reagents-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Hawaii Meetings, Conventions, Incentives (MCI) Tourism Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“Hawaii Meetings, Conventions, Incentives (MCI) Tourism Market is likely to reach nearly USD 1.3 Billion by the year-end of 2022.”

Market growth can be attributed to factors such as Ideal Meetings Location, Unbeatable Event Spaces, Safety, Productive Atmosphere, Accommodations, International Accessibility, Enrichment Opportunities and Natural Wonders.

Japan, US West and US East MCI tourists play a significant role in contributing revenue to the Hawaii economy. Japan contributed more than 30% revenue followed by US East with more than 27% revenue in 2016. Japan is likely to maintain dominance in Hawaii MCI tourist’s revenue generator by the year end of 2022. US East and US West have shown its potential to become 2nd and 3rd major revenue generator countries by the year end of 2022. Other countries such as Other Asia, China and Canada emerge as the largest revenue generator in the Hawaii MCI Tourism Market.

The research report titled ” Hawaii Meetings, Conventions, Incentives (MCI) Tourism Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” provides detailed information on the Hawaii MCI Tourism Market. This report analyzes market data and provides a better understanding of MCI travelers flows and revenue to Hawaii. Market outlook in value terms for the forecasted period for Hawaii MCI tourism market has been detailed in the report. This report also entails a detailed description of market drivers and inhibitors of the Hawaii MCI tourism market.

This 65 Pages report with 52 Figures and 4 Tables have been analyzed from 5 viewpoints:

• Hawaii MCI Travelers, Revenue & Forecast (2013 – 2022)
• Hawaii MCI Travelers, Revenue Share & Forecast (2013 – 2022)
• Hawaii MCI Travelers, Revenue & Forecast – Top 12 Country Analysis (2013 – 2022)
• Hawaii MCI Tourism Market – Market Drivers
• Hawaii MCI Tourism Market – Inhibitors

Hawaii MCI Tourism Market – 12 Countries Covered

• US West
• US East
• Japan
• Canada
• Australia
• New Zealand
• Other Asia
• China
• Korea
• Taiwan
• Europe
• Latin America

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1985-hawaii-meetings,-conventions,-incentives-(mci)-tourism-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

Head & Neck Cancer Drugs Market, Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“The global head & neck cancer drugs market was valued at $1,295 million in 2017, and is projected to reach $2,281 million by 2025, registering a CAGR of 7.3% from 2018 to 2025.”

Head & neck cancers include a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses, lips, salivary glands and mouth. Head and neck squamous cell carcinoma (HNSCC) is the most common form of head & neck cancer, which develops in the mucous membranes of the mouth, nose, and throat. Chemotherapy, immunotherapy & targeted therapy are used for the treatment of head & neck cancer along with the radiation & surgical procedures.

There is an increase in the demand for head & neck cancer drugs owing to the growth in incidence of head & neck cancer, rise in demand for combination therapeutics, higher number of R&D studies, and surge in adoption of immune therapeutics. In addition, growth in the geriatric population and technological advancements in screening & diagnosis of head & neck cancer further drive the market growth. Strong presence of late-stage pipeline drugs such as Ipilimumab, Atezolizumab, Avelumab, Durvalumab, Erlotinib, Afatinib, Bevacizumab, and others are expected to drive the market growth. However, higher cost & adverse effect associated with head & neck cancer drugs are projected to impede the market growth.

The global head & neck cancer drugs market is segmented based on drug class, sales channel, and region. Based on drug class, the market is classified as chemotherapy, immunotherapy, and targeted therapy. According to the sales channel, the market is categorized as hospital pharmacies, drug stores and retail pharmacies, and online stores. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, and rest of LAMEA).

Key Benefits for Head & Neck Cancer Drugs Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
Head & Neck Cancer Drugs Key Market Segments:

By Drug Class

Chemotherapy
Immunotherapy
Targeted Therapy
By Sales Channel

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Stores
By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
List of Key Players Profiled in the Report:

AstraZeneca PLC
Bristol-Myers Squibb Company
Eli Lilly and Company (ARMO Biosciences.)
Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.)
F. Hoffmann-La Roche Ltd. (Genentech, Inc.,)
Immutep Limited
Merck & Co., Inc.
Merck KGaA (EMD Serono, Inc.)
Novartis AG
Pfizer Inc.
List of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request.)

Boehringer Ingelheim
AVEO Pharmaceuticals

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/2224-head-&-neck-cancer-drugs-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Report

Global Diabetes Reusable Insulin Pen Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

Diabetes Reusable Insulin Pen Market is likely to reach more than US$ 3 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.

Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of reusable insulin pen devices.

China is expected to lead the reusable insulin pen market with a total market share of over 50% by 2022. Germany has shown its potential to become leading #2 market with more than XX% market share in 2016 and is expected to maintain its #2 position during the forecast period. United States is expected to become the third largest reusable insulin pen market by 2022.

The research report titled “Global Diabetes Reusable Insulin Pen Market Report: Country Outlook, Analysis, Size, Share and Forecast 2017 – 2022” examines the market, demand, competitive landscape and trends of the ten major markets of the reusable insulin pen market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into reusable insulin pen market and users for the top 10 countries, comprising the US, the UK, France, Italy, Spain, Germany, Japan, China, India and Brazil until 2022. The report also explores detailed description of growth drivers and barriers of the reusable insulin pen market.

The report concludes with the profiles of major players in the insulin pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the insulin pen market.

All the Ten Major Markets(10MM) Covered in the Report Have Studied from 4 Viewpoints

1. Overall Diabetes Population (2011 – 2022)
2. Insulin Users (2011 – 2022)
3. Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
4. Reusable (Cartridge) Insulin Pen Market (2011 – 2022)

Ten Major Markets(10MM) Covered in the Report are as follows:

1. United States
2. United Kingdom
3. France
4. Italy
5. Spain
6. Germany
7. Japan
8. China
9. India
10. Brazil

Key Companies Covered in the Report are as follows:

1. Novo Nordisk
2. Eli Lilly
3. Sanofi
4. Owen Mumford
5. Ypsomed
6. Biocon Ltd.

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1986-global-diabetes-reusable-insulin-pen-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com

Categories
Global Market Market Reports

North America Insulin Pump Market , Trends, Analysis, Opportunities, Share and Forecast 2019-2025

“North America Insulin Pump Market is likely to reach more than US$ 4.2 Billion by the year end of 2022.”

Long–term Growth Projection:

• Number of diabetes population in United States will increase to more than 33 Million by the year end of 2022

• In 2016, there were more than 5,00,000 insulin pump users in United States

• Canada Insulin Pump market generated more than US$ 160 Million in 2016

• The US is the major market share holder for the North America Insulin Pump Market

Increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle–compatible treatment options and technological advancement in insulin pump devices are the key factors driving the growth of the North America Insulin Pump Market. However, high cost of the insulin pump devices is expected to hamper growth of the market during forecast period.

“North America Insulin Pump Market Prospect, Share, Development, Growth and Demand Forecast to 2022” provides a deep and thorough evaluation of the North America Insulin Pump Market. The report provides an in–depth analysis of the type 1, type 2, newly diagnosed type 1 diabetes and overall diabetes population of all the three countries covered in the report. It provides an essential insights of insulin pump users in terms of volume in detail for latest trends, outlook and opportunities in all the three countries covered in the report.

Market outlook in value terms has been analyzed based on current and potential trends and the market is estimated from 2017 to 2022. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Key trends in terms of collaborations, partnerships and licensing agreements are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the North America Insulin Pump Market.

The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation, Tandem Diabetes Care, Microport and Sooil Development. The major market players are evaluated on various parameters such as company overview, product outlook, latest development and trends and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.

Key Topics Covered in the Report

• United States, Canada & Mexico Diabetes Population Analysis (2011 – 2022)
• North America Insulin Pump Users & Market Prospect & Growth (2011 – 2022)
• North America Insulin Pump Users & Market Share – By Countries (2011 – 2022)
• North America Insulin Pump Market Analysis – By Countries (2011–2022)
• United States Insulin Pump Users and Market Analysis (2011 – 2022)
• United States Insulin Pump Preferred Brand – By Product
• Canada Insulin Pump Users and Market Analysis (2011 – 2022)
• Mexico Insulin Pump Users and Market Analysis (2011 – 2022)
• North America (All 3 Countries) Insulin Pump Reimbursement & Regulation System
• North America Insulin Pump Market – Major Deal Types
• Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
• Key Drivers and Inhibitors of the North America Insulin Pump Market
• Key Companies Analysis

Major Countries Covered in This Report:

• United States
• Canada
• Mexico

Major Companies Covered in This Report:

• Insulet Corporation
• Medtronic
• Roche
• Animas Corporation and
• Tandem Diabetes Care
• Microport
• Sooil Development

To request a sample copy or view summary of this report, click the link below:

https://digitsnmarkets.com/sample/1990-north-america-insulin-pump-market

About Digits N Markets:

Digits N Markets has a vast repository of latest market research reports on trending topics, niche company profiles, market size and other relevant data released by renowned publishers. We have access to the database related to niche markets and trending topics in various industries. We also update the data regularly to provide recent statistics to the client. Recent data and reports will be featured on our websites and clients will be able to access the same. Our clients will be able to benefit from qualitative & quantitative insights in the report which will support them in taking concrete business decisions.

Contact Us :

Digits ‘N’ Markets
410 E Santa Clara Street, Unit #762
San Jose, CA 95113
Phone :+1 408-622-0123
Email: [email protected]
Website:- www.digitsnmarkets.com